Kestra Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$829K Buy
+2,144
New +$795K 0.02% 253
2026
Q1
Sell
-1,036
Closed -$363K 462
2025
Q4
$363K Buy
+1,036
New +$350K 0.01% 328
2025
Q3
Sell
-709
Closed -$276K 519
2025
Q2
$276K Buy
709
+122
+21% +$49.1K 0.01% 378
2025
Q1
$255K Sell
587
-627
-52% -$252K 0.01% 349
2024
Q4
$448K Sell
1,214
-151
-11% -$63.2K 0.02% 243
2024
Q3
$710K Buy
+1,365
New +$729K 0.03% 158

Other funds holding ELV

Kestra Investment Management's ELV Position: Q2 2026 in Review

Kestra Investment Management opened a new position in Elevance Health (ELV) in Q2 2026: 2,144 shares worth $829K. The stake represents 0.02% of the portfolio and ranks #253 among its holdings. This is a return to the name: Kestra Investment Management previously reported a position in ELV as recently as Q4 2025.

Kestra Investment Management first reported a position in ELV in Q3 2024 and has held it in 6 quarters since. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Kestra Investment Management held 2,144 shares of Elevance Health worth $829K as of Q2 2026.
  • Elevance Health was a new Kestra Investment Management position in Q2 2026.
  • Elevance Health made up 0.02% of Kestra Investment Management's portfolio in Q2 2026, its #253 holding.
  • Kestra Investment Management first reported a position in Elevance Health in Q3 2024 and has held it in 6 quarters since.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.